Skip to main content

Dermatology and Therapy OnlineFirst articles

Open Access 05.12.2022 | Review

Characterizing Skin Cancer in Transplant Recipients by Fitzpatrick Skin Phototype

In 2021, more than 41,000 transplants were performed in the USA, representing an annual record for the ninth consecutive year [ 1 ]. As transplants continue to increase and patients survive longer, the sequelae of chronic immunosuppression will …

Open Access 01.12.2022 | Original Research

Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)

Psoriasis is a chronic, immune-mediated inflammatory skin disease with multifactorial etiology [ 1 ]. In Europe, the prevalence of psoriasis was approximately 2% [ 2 ], and about one-third of patients have moderate-to-severe psoriasis, which has …

Open Access 30.11.2022 | Letter

Letter to the Editor Regarding a Comprehensive Update of the Atypical, Rare, and Mimicking Presentations of Mycosis Fungoides

Open Access 29.11.2022 | Review

Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region

Atopic dermatitis (AD) is a chronic skin disease that significantly decreases the quality of life of patients [ 1 ]. It may also lead to economic losses for patients and societies, especially in a severe state [ 2 ]. AD is occasionally mistaken for …

Open Access 29.11.2022 | Review

Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review

Acne vulgaris frequently affects women during pregnancy and lactation. Hormonal and physiologic changes in pregnancy contribute to the pathogenesis of acne during the various phases of pregnancy. Several effective acne treatments commonly …

Über diese Zeitschrift

Dermatology and Therapy is focused on cutting-edge research, treatment, and aesthetic interventions in dermatology. Emphasis is placed on articles that investigate the clinical aspects of dermatology, such as skin pharmacology; skin development and aging, prevention, diagnosis, and management of skin disorders; and research into dermal structures and pathology. Articles relating to diagnosis, pharmacoeconomics, outcomes, patient care, management, education, and quality of life are also encouraged. The journal is fully open access, internationally peer-reviewed and offers rapid publication (peer review within 2 week, online 3-4 weeks from acceptance).

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research papers, drug reviews, case reports, and short communications.

Dermatology and Therapy offers a range of additional features designed to enhance the educational content of the research. Each article is accompanied by a bulleted slide summary for a time-efficient overview of the content. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. These features are published alongside the article on the bespoke journal website:

Upon acceptance of your article for publication, you will be required to pay the article open access fee of £230/$360 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.

Dermatology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer.

For more information about the Creative Commons Attribution-Noncommercial License, click here:

Dermatology and Therapy
Volume 1/2011 - Volume 12/2022
Springer Healthcare
Elektronische ISSN
Print ISSN


Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.